Daniella Kranjac is a Founding General Partner at Dynamk Capital. See sector focus and contact routes.
Daniella Kranjac is a Founding General Partner at Dynamk Capital, a New York-based venture firm where she leverages her background as a founder who co-founded Wave Biotech and successfully exited it to GE Healthcare. Her investment thesis targets early-stage life sciences industrials, focusing on companies providing services, tools, and technologies that enable therapeutic discovery, development, and manufacturing, primarily at Series A and B stages in consumer health, biotech, and digital health. She typically invests check sizes ranging from $3.0 million to $10.0 million and is known for supporting female and diverse founders while acting as a lead investor in the biotech sector. Notable portfolio companies include PathAI, Envisagenics, and FloDesign Sonics, where she serves as a board member or observer. Kranjac brings distinctive value through her extensive deal-making experience with multinational biopharma and governments, which provides Dynamk with a broad network of innovators and key opinion leaders. She currently also serves as a Founding GP at Avant Bio, another growth equity firm investing in therapeutic-enabling tech.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like Daniella Kranjac · Full investor directory · Investor access · Company funding database